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В статье описываются два клинических случая оказания помощи пациентам с инфицированными 
аортобифеморальными протезами. В обоих случаях протез был удален. В первом случае было принято ре-
шение сделать экстраанатомическую реваскуляризацию нижних конечностей после полного удаления про-
теза из-за вирулентной инфекции (Staphylococcus aureus и Гр+ бактерии) и протезо-энтеральной фистулы. 
Было выполнено аксило-бифеморальное шунтирование. Во втором случае, когда инфекция была не столь 
вирулентной (Staphylococcus epidermidis), было принято решение провести эндартерэктомию аорты и под-
вздошных артерий, а также для реконструкции использовали бедренную вену. Оперативные вмешательства 
прошли успешно. У обоих пациентов в настоящее время нет признаков инфекции и перемежающейся 
хромоты. Инфекция протеза является одним из наиболее серьезных осложнений аортобифеморального 
шунтирования, поэтому профилактика инфекции очень важна. Важно соблюдать все правила асептики и 
антисептики во время операции. Лечение инфекции протеза основано на внутривенном введении анти-
биотиков и удалении инфицированного синтетического материала. Реваскуляризация конечностей после 
удаления протеза может быть обеспечена путем экстраанатомического шунтирования или артериальной 
реконструкции «in situ».
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Authors describe two case reports of patients with infected aortobifemoral graft. Both were treated by total 
graft excision. In the first case they decided for extra anatomical revascularization of lower extremities after total 
graft excision, because of virulent infection (Staphylococcus aureus and G+ bacteries) and graft enteral fistula. They 
performed axilobifemoral bypass grafting. In the second case, where infection was not so virulent (Staphylococcus 
epidermidis) they decided for in situ reconstruction with desobliterated native aorta, iliac arteries and femoral vein. 
Both patients are now without signs of infection and they can walk without claudication pain. Graft infection is 
one of the most serious complications of aortobifemoral bypass surgery therefore the prevention of infection is very 
important. It is important to keep all rules of asepsis and antisepsis during surgery. Treatment of graft infection is 
based on intravenously administered antibiotics and excision of infected graft. Limb revascularization after graft 
removal can be provided by extra anatomical bypass or in situ arterial reconstruction.
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Introduction
Prothetic graft infection is a feared complication 
of aortic surgery. The reported incidence of infection 
of vascular prosthesis varies. Infection occurs after 
0.2% to 5% of operations and is influenced by the 
implant site, indication for the surgery, concomitant 
disease, and host immune system [1]. Limb loss 
occurs in 25% of cases of infection and mortality 
reaches 40% [2]. The incidence of aortic graft 
infection decreases in last years due to more precise 
asepsis and antisepsis in perioperative period. 
Antibiotics also reduced the risk of infection. Early 
diagnosis and treatment of the graft infections are 
crucial to avoid major complications like sepsis, 
bleeding and to avoid death. Diagnosis is based 
on CT, MRI eventually on PET-CT [1]. Surgical 
treatment includes excision of the infected graft 
and revascularisation by extra anatomical or in situ 
bypass [1, 3].
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Case report 1
Sixty-fouryears old lady came in September 
2009 because of gluteal and femoral claudications 
after 50 m of walking. Except this she suffered 
from chronic ischemic heart disease, hyperten-
sion and diabetes mellitus of the II type. She was 
smoker. Angiography revealed peripheral arterial 
occlusive disease, aortoiliac type, TASC D, which 
was not appropriate to endovascular treatment. 
We performed aortobifemoral bypass grafting with 
silver-coated Dacron graft in September 2009. Post-
operative course was without serious complications 
and patient was discharged home on the twelfth 
postoperative day. In June 2012 she came because 
of thrombosis of right limb of aortobifemoral graft. 
We performed thrombectomy of the right limb of 
the graft and postoperatively PTA of the stenosis 
of the right distal anastomosis. In April 2013 she 
came again because of acute limb ischemia of the 
right lower extremity, we performed thrombectomy 
of the right limb of the graft again and because of 
the persistent stenosis of the distal anastomosis, we 
performed resection of the distal anastomosis with 
extension of the graft distally at the nearest patent 
portion of deep femoral artery. In June 2014 patient 
started to suffer from fever. CRP was elevated. We 
performed CT angiography which revealed false 
aneurysm in right groin (Fig. 1.).
Because of suspicion at infection we resected 
the false aneurysm in the right groin and revascu-
larizated right lower extremity by in-situ saphenous 
graft. Despite of massive antibiotic treatment on the 
tenth postoperative day massive bleeding occurred 
in the right inguinal area. We operated the patient 
immediately and we found massive infection in the 
right groin. We decided for excision of infected graft 
and we restored blood supply to right lower extrem-
ity by extra anatomical iliaco-popliteal lateral bypass 
grafting. Proximal anastomosis was constructed in 
retroperitoneum in macroscopically infection free 
part of the right limb of aortobifemoral graft. The 
graft of extra anatomical bypass was placed on the 
lateral site of the thigh and approach to popliteal 
artery was from lateral incision. CT –angio recon-
struction shows this lateral popliteal extra anatomi-
cal bypass (Fig. 2.).
After excision of the infected graft the right 
groin was left open for secondary healing. Cul-
ture revealed Staphylococcus epidermidis MRSE, 
Staphylococcus haemolyticus MRSH, Proteus mira-
bilis a Pseudomonas aeruginosa. We administered 
massive antibiotic treatment according culture. 
Extra-anatomical bypass was patent and the right 
lower extremity was viable. The right groin healed 
secondary (Fig 3.).
Patient was discharged after ten weeks of hos-
pitalization without signs of infection. The patient 
was followed up then, she was without signs of 
infection, the extra anatomical bypass was patent. 
She started to be septic in February 2015. PET–CT 
revealed increased metabolic activity in the body of 
the prosthesis (Fig 4). 
Septic fever, increased CRP and the focus in 
the body of the prosthesis at PET-CT confirmed 
graft infection of the remnant of the Dacron graft. 
We decided for total graft excision of the whole 
infected graft in March 2015. First we revascu-
larizated limbs by axilobifemoral bypass from left 
axillar artery to left common femoral artery. Then 
we constructed cross over femoro femoral bypass 
Fig. 1. CT-angio, false aneurysm of right distal 
anastomosis – yellow arrow.
Fig. 2. CT-angio, Extra ananatomical iliaco (prosthesis) 
popliteal lateral bypass, anastomoses are marked by 
yellow arrows.
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from left groin to the previously constructed right 
iliacopopliteal lateral bypass which was without signs 
of infection. Then we performed re-laparotomy. We 
found covered perforation of duodenum (part D3) 
that was in direct contact with the Dacron graft. 
The perforation was the direct cause of the infec-
tion. We removed the infected Dacron graft and 
the defect in duodenum was over sewn. We added 
nutrition jejunostomy. There was prolonged bowel 
paralysis in postoperative course. The patient was 
fed by parenteral and enteral nutrition and paren-
teral for two weeks. After two weeks a peroral intake 
of food was able. Cultures from the graft and also 
surrounding tissue were negative but despite the 
negative cultures we administered patient antibiot-
ics according previous cultures. We administered 
vankomycin, meropenem, colimycin and fluconazol 
intravenously.
The patient was discharged at 34th postopera-
tive day. The arterial reconstructions were patent. 
Today she is two years after explantation of the 
infected graft without signs of infection, CRP level 
is normal, arterial reconstructions are patent, she 
is able to walk without claudication by slow walk. 
Case report 2
Fifty-sevenyears old lady came in June 2010 
because of gluteal and femoral claudications after 
20-30 meters of walking. She had been after 
CABG in year 2004 and she was smoker. Except 
this she had no other serious underlying diseases. 
Angiography revealed aortoiliac atherosclerosis, 
TASC D and in July 2010 we also performed 
aortobifemoral bypass grafting with silver-coated 
Dacron graft. Postoperative course was without 
complications and the patient was discharged 
on the 8th postoperative day. Then she was 
followed up, she was without any symptoms and 
she was able to walk without ischemic pain. In 
January 2012 she came because of seroma in 
left groin, we performed puncture of the seroma 
and swab cultures were negative. In February 
2014 she came because of fistula in right groin, 
we performed revision of the right inguinal area 
and we found an abscess. We performed lavage 
and drainage of the abscess and took culture 
that revealed Staphylococcus epidermidis. We 
administered intravenous antibiotic treatment 
(gentamycin, ciprofloxacin and clindamycin) 
according toculture. CRP was not elevated. In May 
2014 she came again because of perigraft fluid in 
the right groin at CT. We performed revision of the 
right groin, again took cultures, performed lavage 
and drainage. Cultures were negative, but despite of 
this we administered gentamycin and vancomycin 
intravenously. In October 2016 the patient came 
again because of pain and fistula in left groin. CRP 
was elevated to 101 mg/l. CT confirmed perigraft 
fluid around whole aortobifemoral graft and false 
aneurysm in the left groin (Fig. 5., Fig. 6.).
We decided for total excision of the infected 
graft. We performed re-laparotomy, we found that 
the whole graft was surrounded by fluid. We did not 
find any communication with gastrointestinal tract. 
Because there was no communication with gastro-
intestinal tract and the previous culture revealed 
Staphylococcus epidermidis, that is less virulent, 
Fig. 3. Right groin: secondary healed. Fig. 4. PET-CT infected prosthesis of aortobifemoral 
graft. Focus of infection is marked by yellow arrow.
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we decided for in situ reconstruction. Aorta and 
both common iliac arteries were desobliterated 
by local endarterectomy. Left external iliac artery 
was revascularised by Vollmar endarterectomy 
from left groin. It was not able to perform Voll-
mar endarterectomy of external iliac artery at the 
right side therefore we reconstructed right iliac 
external artery by right femoral vein. We used in 
situ reconstruction with only autologous material. 
Postoperative course was without complications. 
Cultures from perigraft fluid and the graft were 
negative. But we administered antibiotics (cipro-
floxacin and clindamycin) intravenously. She was 
discharged at the 9th postoperative day at per oral 
antibiotic treatment (ciprofloxacin). She is fol-
lowed up in our out-patient ambulance. Now she 
is without sign of infection, wounds are healed, 
CRP is 15 mg/l. She walks without claudication 
pain; right lower extremity is without edema. 
Discussion
Aortobifemoral bypass grafting is considered 
to be the gold standard of treatment of aortoiliac 
atherosclerosis. Long term results of aortobifemoral 
graft are excellent. Its five-year patency is about 
90%. Late complications are mainly thrombosis of 
the graft, graft infection and also false aneurysm of 
proximal or distal anastomosis. The most serious 
complication is graft infection.
The reported incidence of infection involving 
a vascular prosthesis varies, infection occurs 
after 0.2% to 5% of operations [1]. Aortic graft 
infections can develop months to years after 
implantation, and thus the long-term incidence is 
higher [1, 3]. Local risk factor of graft infection 
is presence of postoperative hematoma or seroma. 
Also repeated trombectomies can increase the risk 
of infections. Underlying diseases like diabetes 
mellitus, malnutrition, corticosteroid drugs therapy 
or chronic renal failure can be also systemic risk 
factor of graft infection [4]. Graft infections are 
caused mainly by Staphylococcus aureus, but 
recently also by Staphylococcus epidermidis or 
G-negative bacteries. G-negative bacteries are 
typical for aortoenetric fistulas [5]. Infections 
caused by Staphylococcus aureus or G-negative 
bacteries are highly virulent. Graft infections 
can lead to bleeding from anastomosis or graft 
occlusion. The source of infection was duodenum 
in our case. The reason of duodenal perforation 
might by technical failure by the first operation. 
There was probably the direct contact of the 
prosthesis with duodenum and this could lead 
to perforation of duodenum with contamination 
of the graft by duodenal content. It is important 
to avoid contact between graft and duodenum. 
Retroperitoneal tissue should be inserted between 
graft and duodenum. If this is not possible, flap 
from omentum should be constructed and inserted 
between duodenum and graft.
Infections caused by Staphylococcus epidermidis 
are less virulent [6]. They can develop months or 
years after the operative period. Typical symptom 
is false aneurysm or periprotetic fluid. Systemic 
signs of infection are not so common. Diagnosis is 
based on clinical symptoms. There can be elevation 
inflammatory markers, CRP or procalcitonine in 
serum. Positivity of hemoculture is not common 
and is referred about 5% [1]. Sonography can reveal 
hematoma, seroma or abscess in subcutaneous tissue 
or around graft. Any presence of perigraft fluid or gas 
bubbles at CT beyond three months after operation 
indicates graft infection. Diagnostic criteria at CT 
consistent with infection include the loss of normal 
tissue planes of the retroperitoneal or subcutaneous 
perigraft structures collections of fluid or gas around 
Fig. 5. CT – Perigraft fluid, yellow arrow.
Fig. 6. Perigraft fluid – yellow arrow, false aneurysm – 
blue arrow.
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the graft, false aneurysm formation, hydronephrosis, 
and adjacent vertebral or bony osteomyelitis. MRI 
provides anatomic imaging equivalent to that of CT 
but is better able to distinguish between perigraft 
fluid and fibrosis on the basis of differences in 
signal intensity between T1- and T2-weighted 
images. All radionuclide imaging techniques aim to 
demonstrate abnormal accumulation of leukocytes 
in perigraft tissue for the diagnosis of graft infection 
but do not provide anatomic detail. However, they 
can be correlated with MRI and CT to delineate 
the anatomic extent of infection. The accuracy of 
indium 111-labeled WBC scans approaches 80% 
to 90% in detecting graft infection [1]. Nowadays 
PET or with combination with CT like PET- CT 
seems to be the most accurate imaging method in 
detection of graft infection. In case of graft enteral 
fistula or graft enteral erosion endoscopy of upper 
abdomen can be helpful. 
The goals of managing vascular graft infections 
involve initial and long-term eradication of the 
local and systemic septic process and maintenance 
of normal arterial perfusion to involved end-
organ and limb tissues. In caseof graft infection, 
the infected part should be excised. The most 
common site of infection of aortobifemoral graft 
is its inguinal portion. When proximal part of limb 
is incorporated into healthy retroperitoneal tissue, 
excision only of the inguinal part of the prosthesis 
can be satisfactory [7]. But when there are signs of 
infection of the whole graft, the prosthesis should 
be excised completely. In case of aortobifemoral 
graft blood supply to extremities should restored. 
There are two possibilities of revascularization of 
limbs, extra-anatomical axilo-bifemoral bypass or 
in-situ bypass. Extra-anatomical bypass is classical 
approach in the treatment of the graft infection in 
this localization that incudes total graft excision, 
blind closure of aortic stump, debridement of grossly 
infected tissue bed and restoring of blood supply 
by axilobifemoral bypass. In case when only limb 
of graft is infected, without infection of the whole 
graft, excision of the infected part may be sufficient. 
The revascularization of the extremity is restored by 
extra-anatomical obturator bypass from healthy part 
of the graft through foramen obturatummedialyto 
popliteal artery. Limb loss is by extraanatomical 
bypass referred 10% to 25%, perioperative mortality 
is 15 to 22%, one-year survival after operation is 
60% to 80% and infection in axilobifemoral bypass 
can be seen in 3% to 25% [2].
Relatively high mortality and morbidity of 
extra anatomical bypasses led to involving of in-
situ reconstructions into the treatment of graft 
infections. Advantage of in situ reconstructions 
is that they are anatomical and with autologous 
material but they are appropriate only for less 
virulent infections. Autologous grafts, cryopreserved 
arterial allograft or antibiotic treated prosthesis can 
be used for in-situ reconstruction. Autologous graft 
can be vein or desobliterated arterial graft. Great 
saphenous vein can be used to replace peripheral 
grafts but is not large enough for insituaortoiliac 
reconstruction. Promising results can be seen by 
using of femoral veins that can replace aorta of 
diameter up to 26 mm. Clagett refers perioperative 
mortality 10%, primary patency 80% after six 
years and early limb loss only 6% using femoral 
vein. Five-year survival was 52% [8]. Only 15% of 
patients had signs of chronic venous insufficiency 
after removal of femoral vein. Occluded aorta 
and common iliac artery can be desobliterated by 
direct endarterectomy. Extrernal iliac artery can 
be desobliterated by endarterectomy by Vollmar 
loop. Such desobliterated external, common iliac 
artery and aorta can serve as autologous arterial in 
situ graft.
A second option for insitu replacement is 
the use of aortic and iliofemoral arterial segments 
harvested from transplant donors and rendered 
nonantigenic by cryopreservation. The results are 
comparable with results of reconstructions with 
femoral vein. But aneurysmatic dilatation, stenosis 
and degeneration of allograft can be seen more 
frequently compared with femoral vein in situ 
reconstruction [9, 10].
Use of antibiotic coated prosthetic conduit for 
in situ replacement of infected grafts is a treatment 
option in selected circumstances. Rifampycin is 
often use for this purpose. When antibiotic coated 
prosthesis is considered to be used for insitu 
reconstruction, the infection should be less virulent 
without systemic signs [7, 11]. Such graft should be 
covered by muscle flap in inguinal area or omental 
flap in peritoneal cavity. Six-week antibiotic therapy 
should be added after placement of antibiotic coated 
prosthesis. Reinfection rate is referred 5-10% [11]. 
Extra-anatomical reconstruction and also in situ 
reconstruction should be followed by 2-6 weeks of 
intravenous antibiotic treatment.
We prefer in situ reconstruction with autologous 
material when it is possible, what we did in the second 
case. In the first case we were afraid of virulent 
infection, because the first in situ reconstruction in 
this patient which was constructed with saphenous 
graft in right inguinal area led to massive bleeding. 
We were afraid that the Staphylococcus aureus 
infection could lead also to infection of insitu 
reconstruction in aortoiliac position with massive 
bleeding from aorta. Therefore, we decided for 
extraanatomical reconstruction, axillobifemoral 
bypass grafting.
Prevention of graft infection is imperative, and 
the surgical team must be cognizant of preoperative, 
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operative, and postoperative prophylactic measures. 
To prevent infection of vascular prosthesis it is 
important to protect vascular grafts from contact with 
any potentially contaminating source, especially the 
exposed skin adjacent to the operative field, with the 
use of iodine impregnated plastic drapes. Concomitant 
gastrointestinal procedures during cavitary grafting 
procedures should be avoided to prevent contamination 
of the graft with enteric organisms [1]. It is important 
to avoid direct contact of the graft with duodenun to 
prevent graft enteral fistula.
Conclusions
Graft infection in aortoiliac position is one of 
the most serious complications of bypass surgery 
and is associated with high mortality and morbidity. 
Diagnosis is based on clinical symptoms, elevation of 
inflammatory markers like CRP and procalcitonin. 
Imaging methods like CT, MRI or PET-CT can 
help to confirm the diagnosis. The treatment 
is intravenous administration of antibiotics and 
excision of the infected graft. After removal of the 
infected graft, blood supply to extremities should be 
restored. One of the possibilities is extra-anatomical 
bypass and the second is in situ reconstruction. The 
best outcomes are with autologous graft like femoral 
vein or desobliterated arteries. Graft infection is one 
of the most serious complications of aortobifemoral 
bypass surgery therefore the prevention of infection 
is very important. It is important to keep all rules 
of asepsis and antisepsis during surgery.
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